These data suggest that LRRC15 regulates macrophage activation through IL‐17 and NF‐kappa B signaling pathways and subsequently contributes to CAVD and OA development, but further validation experiments are required. This evidence concerns the gene LRRC15 and congenital bilateral aplasia of vas deferens from CFTR mutation.